ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.49
-0.02 (-0.80%)
At close: May 14, 2025, 3:59 PM
2.50
0.40%
Pre-market: May 15, 2025, 05:27 AM EDT
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending March 31, 2025, ImmunityBio generated $16.52M in revenue.
Revenue (ttm)
$14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
$21.68K
Employees
680
Market Cap
2.2B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|